BeiGene, Ltd., a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer, announced that updated clinical data from an ongoing Phase 1 A/1B trial of tislelizumab, an investigational anti-PD-1 antibody, were presented in an oral...
-Bellicum Pharmaceuticals, Inc., a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today reported safety and promising activity of BPX-601 in Part 1 of a Phase 1/ 2 dose-escalation study in patients with advanced, metastatic pancreatic cancer expressing PSCA. Data were reviewed dur
Albany, NY 12/14/2018 Global Bovine Blood Plasma Derivatives Market: Snapshot. Bovine blood plasma derivatives are exclusive in a way when it comes to delivering palatability, something that cannot be achieved via other alternatives such as plant extracted proteins and other synthetic nutrient elements. The analysts of the report have evaluat
Brazil`s Butantan Institute signed a collaboration agreement with Merck Sharp& Dohme to develop dengue vaccines. The vaccine developed by Butantan Institute with So Paulo Research Foundation- FAPESP`s support is currently in the last phase of trials involving humans, with 17,000 volunteers participating. The agreement also allows for exclusive...
-Jin Y. Kim, a leading board-certified periodontist who has dedicated his career to learning and contributing to the latest in periodontal care welcomes people withperiodontal diseasein Chino Hills, CA, to take advantage of LANAP, the FDA- cleared laser gum therapy treatment he offers. When patients work with Dr. Kim to properly address their gum d
LAKEWOOD, Colo. 2018 Elijah Gonzalez can only eat through a feeding tube. "The only drug that could really help him save his live is called tazemetostat manufactured by Epizyme," said Elijah's father Cesar Gonzalez. Yet the 41- year old Lakewood dad said the Massachusetts- based pharmaceutical company Epizyme has not been willing to make its exp
PEOPLE should eat dark, leafy greens and dark chocolate as well as taking supplements to get the proper dose of the sunshine vitamin D during the dark winter months, scientists say. Scotland has the lowest levels of vitamin D, due to a lack of sunshine and a diet low in oily fish. Research professor, Dr Martha Shrubsole, at Vanderbilt University Me
Albany, NY 12/15/2018 In order to study the various trends and patterns prevailing in the concerned market, Market Research Reports Search Engine has included a new report titled " Injectable Drug Delivery Market" to its wide online database. This research assessment offers a clear insight about the influential factors that are expected to tr
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease inhibitors, today provided an operational update and released financial results for the fiscal second quarter ended October 31, 2018. We are still on track with our robust Phase 2 study for
Rockville, MD 12/14/2018 Magnesium Lactate Market Introduction:. Magnesium lactate is a magnesium salt of lactic acid and commonly used ingredient added to food and beverages as an acidity regulator. It is also used as a dietary supplement and as a nutrient in different formulation.
Last night, U.S. Senator Rob Portman delivered remarks on the Senate floor about the bipartisan Permanent Subcommittee on Investigations report, which was highlighted on 60 Minutes, that found the drug manufacturer kaleo increased the price of its opioid overdose reversal drug by more than 600 percent to "capitalize on the opportunity" of "opioid o
Orbital ATK, Dulles, Virginia, and EpicentRx, La Jolla, California, have been assigned a patent developed by seven co-inventors for "cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof." The co-inventors are Mark D. Bednarski, Los Altos, California, Susan Knox, Stanford, California, Louis Cannizzo, Ogden, Utah, Kirstin Warn
-Orchard Therapeutics, a leading commercial-stage biopharmaceutical company dedicated to transforming the lives of patients with serious and life-threatening rare diseases through innovative gene therapies, and SIRION Biotech GmbH today announced the entry into a license agreement, pursuant to which Orchard has licensed SIRIONs LentiBOOST...
New York, NY 12/15/2018 Prefilled Syringe Contract Manufacturing Market: Introduction. Prefilled syringes is an important innovations by pharmaceutical industries to provide new vision for syringe medication which provide a new growth opportunities. Prefilled syringes are prospects for patients who are under treatment and need drug administra
Boehringer Ingelheim Pharmaceuticals intends to find out and the Ridgefield giant is not following the script of its competitors. "Boehringer Ingelheim believes the introduction of high-quality, lower-cost biosimilars is critical for both patients and the sustainability of the system," stated Susan Holz, a Boehringer Ingelheim spokesperson in...
-Sonoma Pharmaceuticals, Inc., a specialty pharmaceutical company that develops and markets unique and effective solutions for the treatment of dermatological conditions and advanced tissue care, today announced a series of management changes. Mr. Sandford, 57, has over 30 years of experience leading companies in several industries and at various s
-If Authorized in Europe, ADCETRIS in Combination with AVD Will Be the First New Treatment Regimen Available for Adult Patients with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma in Decades. Takeda Pharmaceutical Company Limited today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use adopted a posi
New York- based tech CRO TrialSpark launched its first clinical trial sites as part of a partnership with Novartis that takes a new direction. TrialSparks approach addresses issues with trial participants who dont live near large academic centers or hospital-based trial sites by allowing them to participate at their local doctors office.
But for Boston- based XenoTherapeutics, pigskin means a potential treatment option for burn victims. Earlier this week, the U.S. Food and Drug Administration cleared the companys Investigational New Drug Application to allow the company to initiate clinical studies with Xeno-Skin, a product designed to provide help for patients who have suffered fr
I have written this top ten list for years and each time I "try" to write an introduction that is funny or which contains a quote that is uplifting and appropriate for the current year. That is what unites Alabama healthcare providers. I am reminded of this when I read about the citizens of Sumter and Chilton Counties who passed a sales tax to keep
The "Recent Developments in Aquaponics, Nutritive Supplements, Carbon Capture, and Biobricks" report has been added to ResearchAndMarkets.com' s offering. Antarctic Krill-based Nutritive Supplements for Animals and Humans Patented Carbon Capture Technologies for Coal-based Power Plants Modular and Scalable Indoor Aquaponic Farms with More Food...
DRUG$, a new documentrary that explores the mystery of modern medicine s skyrocketing price tag here in the U.S. and how it affects people struggling to stay alive, begins a weeklong theatrical run in Los Angeles at the Laemmle Music Hall 3 in Beverly Hills starting Friday, December 14 th. About AIDS Healthcare Foundation and why we produc
-Adial Pharmaceuticals, Inc., www.adialpharma.com, a clinical-stage biopharmaceutical company focused on the development of medicines for addiction, today announced plans to expand activities around the Companys lead asset, AD04, beyond alcohol use disorder, to now include its potential use in patients with opioid use disorder. William Stilley, CEO
Today`s Daily Dose brings you news about disappointing trial results of Applied Genetic Technologies; near-term catalyst of Idera; stock offering of Marinus; disappointing Tourette syndrome trial results of Neurocrine Biosciences; bankruptcy proceedings of Synergy Pharma; Complete Response Letter for Mallinckrodt`s pain drug, and promising data fro
Alder BioPharmaceuticals, Inc., a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today reported that the Compensation Committee of Alder s Board of Directors granted a non-qualified stock option to purchase an aggregate of 270,000 shares of Alder s common stock to Carlos E. Campoy